113.05
price up icon2.07%   2.29
pre-market  시장 영업 전:  114.84   1.79   +1.58%
loading

Cidara Therapeutics Inc (CDTX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - 0.302
Operating Expenses
8.37%
27.38
25.27 54.18 17.39 96.29
Depreciation and Amortization
25.00%
0.027
0.036 0.04 0.041 0.037
Operating Income/Loss
8.37%
-27.38
-25.27 -54.18 -17.39 -95.98
Income/Loss From Continuing Operations Before Tax
9.53%
-25.72
-23.48 -52.37 -15.54 -94.21
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
9.53%
-25.72
-23.48 -52.37 -15.54 -94.21
Income/Loss From Discontinued Operations, Net Of Tax
-
- 0.062 -0.45 3.001
Net Income/Loss
9.53%
-25.72
-23.48 -52.31 -15.98 -91.21
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.66%
15.55
14.18 1.1343 6.5301 4.5638
Diluted Average Shares
9.66%
15.55
14.18 1.1343 6.5301 4.5638
Basic Earnings Per Share
0.60%
-1.65
-1.66 -4.22 -2.45 -19.99
Diluted Earnings Per Share
0.60%
-1.65
-1.66 -4.22 -2.45 -19.99
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
자본화:     |  볼륨(24시간):